Bend Research and Catalent Enter Into Agreement

August 16, 2012
Drug Discovery News

Late June saw Bend Research Inc. and Somerset, N.J.-based Catalent Pharma Solutions Inc. enter into an agreement to provide integrated solutions for pharmaceutical companies that are seeking to develop and manufacture specialized multiparticulate oral controlled-release products. The team-up is particularly focused on bringing complex controlled-release products to market faster and more efficiently with optimal therapeutic and release profiles.